Sangamo Therapeutics Announces Participation In The ARM 5th Annual Cell & Gene Therapy Investor Day – PR Newswire (press release)
|
Sangamo Therapeutics Announces Participation In The ARM 5th Annual Cell & Gene Therapy Investor Day
PR Newswire (press release) Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into genomic therapies that transform patients' lives using the company's industry leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. |
